C143H161F4N25O22S — CID 158739967
2-(2-cyanopropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-fluoropropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-2-methylsulfonylpyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide (PubChem CID 158739967) has the molecular formula C143H161F4N25O22S and a molecular weight of 2690.07 g/mol. Its IUPAC name is 2-(2-cyanopropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-fluoropropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-2-methylsulfonylpyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide.
| Compound Name | 2-(2-cyanopropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-fluoropropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-2-methylsulfonylpyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide |
|---|---|
| PubChem CID | 158739967 |
| Molecular Formula | C143H161F4N25O22S |
| Molecular Weight | 2690.07 g/mol |
| Exact Mass | 2688.19 |
| IUPAC Name | 2-(2-cyanopropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;6-cyclopropyl-N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]pyridazine-4-carboxamide;2-(2-fluoropropan-2-yl)-N-[6-methyl-5-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]-3-pyridinyl]pyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-2-methylsulfonylpyridine-4-carboxamide;N-[4-methyl-3-[5-morpholin-4-yl-6-(oxan-4-yloxy)-3-pyridinyl]phenyl]-6-(trifluoromethyl)pyridazine-4-carboxamide |
| SMILES | Cc1ccc(NC(=O)c2ccnc(S(C)(=O)=O)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cnnc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1.Cc1ccc(NC(=O)c2cnnc(C3CC3)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1.Cc1ncc(NC(=O)c2ccnc(C(C)(C)C#N)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1.Cc1ncc(NC(=O)c2ccnc(C(C)(C)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1 |
| InChI | InChI=1S/C30H34N6O4.C29H34FN5O4.C29H33N5O4.C28H32N4O6S.C27H28F3N5O4/c1-20-25(16-23(18-33-20)35-28(37)21-4-7-32-27(15-21)30(2,3)19-31)22-14-26(36-8-12-39-13-9-36)29(34-17-22)40-24-5-10-38-11-6-24;1-19-24(16-22(18-32-19)34-27(36)20-4-7-31-26(15-20)29(2,3)30)21-14-25(35-8-12-38-13-9-35)28(33-17-21)39-23-5-10-37-11-6-23;1-19-2-5-23(32-28(35)22-14-26(20-3-4-20)33-31-18-22)16-25(19)21-15-27(34-8-12-37-13-9-34)29(30-17-21)38-24-6-10-36-11-7-24;1-19-3-4-22(31-27(33)20-5-8-29-26(16-20)39(2,34)35)17-24(19)21-15-25(32-9-13-37-14-10-32)28(30-18-21)38-23-6-11-36-12-7-23;1-17-2-3-20(33-25(36)19-13-24(27(28,29)30)34-32-16-19)14-22(17)18-12-23(35-6-10-38-11-7-35)26(31-15-18)39-21-4-8-37-9-5-21/h4,7,14-18,24H,5-6,8-13H2,1-3H3,(H,35,37);4,7,14-18,23H,5-6,8-13H2,1-3H3,(H,34,36);2,5,14-18,20,24H,3-4,6-13H2,1H3,(H,32,35);3-5,8,15-18,23H,6-7,9-14H2,1-2H3,(H,31,33);2-3,12-16,21H,4-11H2,1H3,(H,33,36) |
| InChIKey | IMDYKPWTXBTMGW-UHFFFAOYSA-N |
| XLogP | 21.38 |
| TPSA | 538.54 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 34 |
| Heavy Atoms | 195 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2690.07 |
| LogP ≤ 5 | 21.38 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 42 |